ARCHIVES

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NIH Extramural Office Lists Initiatives For Reinvention

January 13, 1995

Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues.

May 5, 2006

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

Coffee, Soft Drinks Have Little Association With Colon Cancer

May 28, 2010

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991